Simulations Plus (SLP) Reports Q3 EPS of $0.11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Simulations Plus Reports Third Quarter FY2016 Financial Results
July 14, 2016 4:01 PM EDTRecord quarterly revenue, 9moFY16 diluted EPS increased 23% to a record $0.242 from $0.196
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its third quarter of fiscal year 2016 (3QFY16) and the first nine months of fiscal year 2016 (9moFY16), the period ended May 31, 2016.
3QFY16 highlights compared with 3QFY15:
Net revenues increased 1.2% to $6.01 million, an increase of $70,000 from $5.94 million... More